paralysis
01/02/2018 / By Robert Jonathan
Drug makeover: When a drug underperforms, Big Pharma renames it, labels it for another use and jacks up the price
A drug that treats periodic paralysis may be pricing those afflicted with the condition out of the market. Originally a medicine approved for glaucoma treatment, the U.K. National Health Service made Daranide available for the equivalent of about $500 U.S. dollars for a year’s supply. Daranide reportedly didn’t work well for the eye disease, but was […]
1 of 1

Health.News is a fact-based public education website published by Health News Features, LLC.

All content copyright © 2018 by Health News Features, LLC.

Contact Us with Tips or Corrections

All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.